Company intelligence / Profile preview
ExpreS2ion Biotechnologies
Hørsholm, N/A, Denmarkexpres2ionbio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Phase 2
01
Overview
ExpreS2ion’s lead candidate ES2B-C001, a therapeutic vaccine for HER2-positive breast cancer, has entered Phase I clinical trials after promising preclinical results. The company’s technology has also been validated in multiple academic and partnered vaccine programs, including malaria candidates with the University of Oxford currently undergoing several clinical studies. The COVID‑19 vaccine ABNCoV2 using their platform reached Phase III via partners.[8][9][10]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Recombinant proteinsVirus-like particles (VLPs)Therapeutic vaccinesProphylactic vaccines[5][6][8]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
– University of Oxford (malaria vaccines)[10]– Evaxion Biotech A/S (cytomegalovirus project)[7]– Copenhagen University/INDIGO consortium (influenza project)[7]– WuXi Vaccines (“Letter of Intent” to evaluate the platform for bioproduction)[1][4]– AdaptVac joint venture for cVLP technology/COVID–19 program [3]
Beyond the preview
Go deeper on ExpreS2ion Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExpreS2ion Biotechnologies.